Cargando…
Topical calcineurin inhibitors in systemic lupus erythematosus
Cutaneous lupus erythematosus (CLE) encompasses a variety of lesions that may be refractory to systemic or topical agents. Discoid lupus erythematosus (DLE) and subacute cutaneous lupus erythematosus (SCLE) are the most common lesions in clinical practice. The topical calcineurin inhibitors, tacroli...
Autores principales: | Lampropoulos, Christos E, D’Cruz, David P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857609/ https://www.ncbi.nlm.nih.gov/pubmed/20421909 |
Ejemplares similares
-
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
por: Sticherling, Michael
Publicado: (2011) -
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
por: Rafael-Vidal, Carlos, et al.
Publicado: (2021) -
Editorial: Cutting edge in systemic lupus erythematosus
por: D’Cruz, David P., et al.
Publicado: (2017) -
Novel therapeutic agents in clinical development for systemic lupus erythematosus
por: Jordan, Natasha, et al.
Publicado: (2013) -
Old and New Calcineurin Inhibitors in Lupus Nephritis
por: Ponticelli, Claudio, et al.
Publicado: (2021)